Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3823634 | Progrès en Urologie | 2011 | 7 Pages |
Abstract
In the absence of current recommendations, it is advised to stop bevacizumab at least five weeks before a surgical intervention and to take it back 4 weeks later. For the tyrosine kinase inhibitors, the treatment can be stopped 24-48Â hours before the surgery and taken back 3-4 weeks later. Finally, for the mTOR inhibitors, it is advised to stop the treatment 7-10 days before and to take back it at least 3 weeks later.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
G. Pignot, T. Lebret, D. Chekulaev, M. Peyromaure, D. Saighi, T. Flam, D. Amsellem-Ouazana, B. Debre, M. Zerbib,